ISPC
iSpecimen Inc.
There isn't enough reported data to score ISPC yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
ISPC Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Unavailable | |
| Unavailable |
ISPC's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
ISPC PE Valuation
ISPC has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
ISPC Forward outlook
There aren't enough analyst estimates for ISPC to show an outlook.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
ISPC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$53.64 | +$674.36 |
| Q1 2026 | -$69.46 | +$793.74 |
| Q4 2025 | -$91.20 | +$999.60 |
| Q3 2025 | -$663.20 | +$116.80 |
| Q2 2025 | -$728.00 | +$152.00 |
| Q1 2025 | -$863.20 | +$176.80 |
| Q4 2024 | -$1,090.80 | -$106.80 |
| Q3 2024 | -$780.00 | +$108.00 |
ISPC is still losing money, but far less than before: $53.64 per share over the past year, against $1,090.80 at its worst in late 2024.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.83 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over ISPC on earnings quality, reporting a profit while its opponent remains loss making.
ISPC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $151.9K | -79% |
| Q1 2026 | $156K | -85% |
| Q4 2025 | $51.8K | -96% |
| Q3 2025 | $106.6K | -96% |
| Q2 2025 | $713.1K | -75% |
| Q1 2025 | $1.1M | -54% |
| Q4 2024 | $1.5M | -43% |
| Q3 2024 | $2.7M | -4.2% |
ISPC's revenue has slid since its 2022 peak: $151,940 last quarter, down 79% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -897% | -642 points |
| Q1 2026 | -1627% | -1472 points |
| Q4 2025 | -5193% | -4797 points |
| Q3 2025 | -2655% | -2591 points |
| Q2 2025 | -255% | -179 points |
| Q1 2025 | -155% | -24 points |
| Q4 2024 | -396% | -284 points |
| Q3 2024 | -64% | +15 points |
ISPC's operating margin was −897% last quarter, down 642 points from the same quarter a year ago.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over ISPC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over ISPC on profitability, with a higher operating margin.
ISPC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$916.9K | +$2.7M |
| Q3 2025 | -$2M | -$941.6K |
| Q4 2024 | -$3.6M | -1137% |
| Q3 2024 | -$1.1M | +$545.5K |
| Q2 2024 | -$1.5M | +$159.8K |
| Q1 2024 | -$2.1M | +$752.1K |
| Q1 2023 | -$2.8M | -$1.5M |
LLY has the stronger cash trend. Its trailing FCF is up 259% versus its history, compared with ISPC at down 40%.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY generated $19.7B in free cash flow over the past year, up 112% from the year before.
ISPC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +308% | +1.1M shares |
| 1 year | +2301% | +1.3M shares |
| 3 years | +12322% | +1.4M shares |
ISPC has 1M diluted shares, up 2301% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $52,500 |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over ISPC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
ISPC Net Leverage
ISPC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
ISPC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.7 | Oversold |
| Stochastic | 3.4 | Oversold |
ISPC's weekly RSI is 26 (oversold) and its Stochastic is 3 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
ISPC PE vs Healthcare Sector
ISPC has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
ISPC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.94 | 26% below |
| 20 week MA | $1.53 | 54% below |
| 50 week MA | $6.03 | 88% below |
| 100 week MA | $29.8 | 98% below |
| 200 week MA | $303.4 | 100% below |
ISPC is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over ISPC on trend strength, trading above more of its moving averages.
ISPC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $5,992.0 | $9,288.0 | +55% |
| 2022 | $9,288.0 | $1,056.0 | -89% |
| 2023 | $1,056.0 | $400.4 | -62% |
| 2024 | $400.4 | $112.4 | -72% |
| 2025 | $112.4 | $15.3 | -86% |
| 2026 YTD | $15.3 | $0.70 | -95% |
ISPC has finished four years in a row lower, and it's down 95% so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over ISPC on returns for 2026, with the stronger performance.